Caxton Associates (New York)’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
DSA
BHG
LAM
LCM
Caxton Associates (New York)'s ADNT Position: Q3 2018 in Review
Caxton Associates (New York) sold out of Adient (ADNT) in Q3 2018, closing a stake of 4,284 shares — an estimated $211K sold.
Caxton Associates (New York) first reported a position in ADNT in Q2 2018 and held it in 1 quarter. The position peaked at $211K in Q2 2018. 401 funds tracked by Wall St. Rank hold ADNT as of Q3 2018.
- Caxton Associates (New York) reported no remaining Adient position as of Q3 2018 after selling out during the quarter.
- Caxton Associates (New York) sold 4,284 Adient shares in Q3 2018, an estimated $211K.
- Caxton Associates (New York) first reported a position in Adient in Q2 2018 and held it in 1 quarter.
- Caxton Associates (New York)'s Adient position peaked at $211K in Q2 2018.
- 401 funds tracked by Wall St. Rank held Adient as of Q3 2018.
Based on Caxton Associates (New York)'s 13F filing for Q3 2018, filed 14 Nov 2018.